PRKAA2 and cardiac hypertrophy: Fructose-bisphosphate aldolase A (ALDOA), a protein that was uniquely significantly associated with oHCM in this study, has been investigated as a therapeutic target for cardiac hypertrophy, whereby knockdown of ALDOA represses development of cardiac hypertrophy through activation of the AMPK signalling pathway [22].